T4	Treatment 25 28	VGB
T5	Effect 40 58	visual dysfunction
T6	Subject 62 80	pediatric patients
T8	Age 62 71	pediatric
T9	Drug 25 28	VGB
T3	Adverse_event 29 39	associated
E1	Adverse_event:T3 
